Showing results (61-70 of 261) with videos related to

Sort By:
Pageof 27
Biochemistry|January 17, 1995
Structure and properties of the bacteriochlorophyll binding site in peripheral light-harvesting complexes of purple bacteriaJ N Sturgis, V Jirsakova, F Reiss-Husson, et al.
Respiratory Medicine|January 13, 2009
Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthmaSusan Lu, Nancy Liu, S Balachandra Dass, et al.
Thorax|February 5, 2004
Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitationS A Green, M-P Malice, W Tanaka, et al.
Controlled Clinical Trials|April 12, 2002
Quality assurance of asthma clinical trialsKerstin Malmstrom, Iza Peszek, Al Botto, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 23, 2017
Adverse events are rare after single-dose montelukast exposures in childrenDonald H Arnold, Nena Bowman, Theodore F Reiss, et al.
Environmental Research|June 11, 1991
Effects of 0.60 PPM nitrogen dioxide on circulating and bronchoalveolar lavage lymphocyte phenotypes in healthy subjectsI Rubinstein, T F Reiss, B G Bigby, et al.
Comprehensive Therapy|June 30, 2001
Use of oral montelukast in the treatment of asthmaG P Noonan, B Williams, R Angner, et al.
Biophysical Journal|August 18, 2001
Self diffusion and spectral modifications of a membrane protein, the Rubrivivax gelatinosus LH2 complex, incorporated into a monoolein cubic phaseN Tsapis, F Reiss-Husson, R Ober, et al.
The American Journal of Physiology|December 11, 1989
Local mediator release after antigen challenge of a bronchial segment in allergic dogsT F Reiss, I Rubinstein, D L Emery, et al.
Archives of Internal Medicine|June 13, 1998
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study GroupT F Reiss, P Chervinsky, R J Dockhorn, et al.
Pageof 27